Cargando…
Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
Patients with sickle cell disease (SCD) have a high prevalence of RBC alloimmunization. However, underlying mechanisms are poorly understood. Given that proinflammatory type 1 interferons (IFNα/β) and interferon stimulated genes (ISGs) promote alloimmunization in mice, we hypothesized that IFNα/β ma...
Autores principales: | Madany, Emaan, Lee, June, Halprin, Chelsea, Seo, Jina, Baca, Nicole, Majlessipour, Fataneh, Hendrickson, Jeanne E., Pepkowitz, Samuel H., Hayes, Chelsea, Klapper, Ellen, Gibb, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813163/ https://www.ncbi.nlm.nih.gov/pubmed/35128535 http://dx.doi.org/10.1002/jha2.270 |
Ejemplares similares
-
A practical and effective strategy in East Asia to prevent anti‐D alloimmunization in patients by C/c phenotyping of serologic RhD‐negative blood donors
por: Ito, Shoichi, et al.
Publicado: (2021) -
Homozygous sickle cell disease related mortality in Senegal (2011–2020)
por: Seck, Moussa, et al.
Publicado: (2021) -
Sickle cell disease patients with COVID‐19 in Guadeloupe: Surprisingly favorable outcomes
por: Bernit, Emmanuelle, et al.
Publicado: (2022) -
Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease
por: Glaros, Alexander K., et al.
Publicado: (2022) -
Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysis
por: Manwani, Deepa, et al.
Publicado: (2022)